Latest Breaking News On - Amgen celgene otezla - Page 1 : comparemela.com

Share this article Share this article ResearchAndMarkets.com s offering. The North America life science tools market size is expected to reach USD 81.9 billion by 2027 registering a CAGR of 11.6% The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities. Competitive dynamics continue to drive a rapid pace of innovation in sequencing, multiplex platforms, and major categories of mass spectrometry and liquid chromatography; this supports growth via upgrade/replacement cycles and expands the applicability of technologies. An increase in investments for R&D of life science tools is expected to drive the market significantly.

United statesAbbvie allerganMiltenyi biotecBristol myers squibb celgeneAmgen celgene otezlaTransfection electroporationLaura woodMovement analysisGenomic technologyBiopharmaceutical companyProteomics technologyPerkinelmer incOther analytical sample preparation technologyAgilent technologiesMerck kgaRad laboratories inc